angiotensin ii has been researched along with 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, X; Lu, L; Miao, N; Shen, Y; Wang, B; Xu, D; Xu, J; Xue, H; Yang, L; Zhang, W; Zhou, L | 1 |
1 other study(ies) available for angiotensin ii and 5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one
| Article | Year |
|---|---|
c-Myc promotes renal fibrosis by inducing integrin αv-mediated transforming growth factor-β signaling.
Topics: Angiotensin II; Animals; Extracellular Matrix; Fibroblasts; Fibrosis; Folic Acid; Integrin alphaV; Kidney; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-myc; Renal Insufficiency, Chronic; Signal Transduction; Thiazoles; Transforming Growth Factor beta; Up-Regulation; Ureteral Obstruction | 2017 |